Insulet Corporation (PODD)

Healthcare
$146.92▼ 0.77 (0.52%)
Real-time prices · US Markets
📅
Next earnings: Aug 6
Very Bullish
8.5 / 10
Earnings growing 159% year-over-year on 34% revenue growth.
Quality
7.5
Health
7.9
Growth
9.7
Valuation
9.1
Sentiment
8.4
Analyst Target
$242.43
▲ +65.0% from current

Price Chart

Fundamentals

Trailing P/E
34.3×
price-to-earnings
Forward P/E
18.2×
next 12 months est.
Market Cap
$10.2B
market capitalization
Div Yield
dividend yield
Profit Margin
10.4%
net profit margin
Gross Margin
71.0%
revenue minus COGS
ROE
23.0%
return on equity
Beta
1.13
vs S&P 500
52-Week Range
$141 — $355
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

What do analysts say about Insulet Corporation right now?
Insulet Corporation's Q·Score is 8.5/10 (Very Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. Earnings growing 159% year-over-year on 34% revenue growth. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for PODD?
The consensus price target for PODD is $242.43, based on ratings from 23 Wall Street analysts. This is 65.0% above the current price of $146.92. Price targets are forward-looking estimates and not guarantees of future performance.
Is PODD overvalued or undervalued?
Insulet Corporation (PODD) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 18.2×. The consensus analyst price target of $242.43 is 65% above the current price.
When does Insulet Corporation report its next earnings?
Insulet Corporation's next earnings report is expected on approximately August 6, 2026.
What is Insulet Corporation's profit margin?
Insulet Corporation has a net profit margin of 10.4%, which is solid for most industries. Its gross margin stands at 71.0%, indicating a high-margin business model.
Is Insulet Corporation's revenue growing?
Insulet Corporation is reporting strong year-over-year growth of 33.9%. Earnings are also growing at 159.0%, indicating improving profitability.
How much debt does Insulet Corporation have?
Insulet Corporation has a debt-to-equity ratio of 0.78×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 2.49×, indicating comfortable short-term liquidity.
Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026